The Solution: dtb-instilla (direct-to-bladder) Targeted Therapy
The dtb-instilla is a drug delivery system that consists of a single-use disposable device that dispenses a precise dose of the medication directly into the bladder.
UroPharma’s patented technologies, coupled with drugs already licensed for bladder treatments and new drugs, will directly target the urinary bladder rather than expose the entire body to the medications.
This overcomes many of the shortcomings of current approaches to treatments of bladder afflictions.
Through the integration of its unique drug-delivery system, dtb-instilla, along with its pharmaceutical therapies UroPharma intends to:
Improve the quality of care for patients.
Reduce the risk of urinary tract infections.
Reduce total costs of care for payers and providers.